51 related articles for article (PubMed ID: 36183057)
41. Describing settings of care in the last 100 days of life for cancer decedents: a population-based descriptive study.
Hafid A; Howard M; Webber C; Gayowsky A; Scott M; Jones A; Hsu AT; Tanuseputro P; Downar J; Conen K; Manuel D; Isenberg SR
Cancer Med; 2023 Feb; 12(4):4809-4820. PubMed ID: 36281530
[TBL] [Abstract][Full Text] [Related]
42. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.
Bekelman JE; Halpern SD; Blankart CR; Bynum JP; Cohen J; Fowler R; Kaasa S; Kwietniewski L; Melberg HO; Onwuteaka-Philipsen B; Oosterveld-Vlug M; Pring A; Schreyögg J; Ulrich CM; Verne J; Wunsch H; Emanuel EJ;
JAMA; 2016 Jan; 315(3):272-83. PubMed ID: 26784775
[TBL] [Abstract][Full Text] [Related]
43. Care pathways at end-of-life for cancer decedents: registry based analyses of the living situation, healthcare utilization and costs for all cancer decedents in Norway in 2009-2013 during their last 6 months of life.
Bjørnelv G; Hagen TP; Forma L; Aas E
BMC Health Serv Res; 2022 Oct; 22(1):1221. PubMed ID: 36183057
[TBL] [Abstract][Full Text] [Related]
44. End-of-Life Care Interventions: An Economic Analysis.
Pham B; Krahn M
Ont Health Technol Assess Ser; 2014; 14(18):1-70. PubMed ID: 26339303
[TBL] [Abstract][Full Text] [Related]
45.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
46.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
